查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球糖尿病足潰瘍市場——2023-2030 年
市場調查報告書
商品編碼
1279711

全球糖尿病足潰瘍市場——2023-2030 年

Global Diabetic Foot Ulcer Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

全球糖尿病足潰瘍市場預計將以有利可圖的速度增長，到 2022 年將達到 58.127 億美元，到 2030 年將達到 93.06 億美元。 在預測期內（2023-2030 年），糖尿病足潰瘍市場預計將以 6.2% 的複合年增長率增長。 糖尿病足潰瘍是糖尿病控制不佳的最常見後果之一。 血糖控制不佳、潛在的神經病變、外周血管疾病或足部護理不當是糖尿病足潰瘍的常見原因。

糖尿病足潰瘍是糖尿病患者面臨的最嚴重的問題之一，因為身體癒合傷口的能力嚴重受損。 通常，患者的腿會酸痛，並在該特定位置迅速腐爛並產生傳染性細菌。

市場動態

糖尿病足潰瘍的患病率增加

糖尿病最嚴重、最嚴重的後果之一就是糖尿病足潰瘍。 隨著糖尿病患病率的增加，問題的數量也在增加。 有許多因素會增加糖尿病足潰瘍的發病率，包括年齡增長、久坐不動的生活方式和糖尿病病程延長。

治療技術進步

最新的手機可以拍攝與商用數碼相機相當的高分辨率 DFU 圖像。 目前，許多患者使用手機圖片自行管理 DFU。 此外，還有部分患者攜帶照片到足科進行DFU治療的跟進，定期觀察傷口的進展情況。

患者還可以在線或將圖像作為電子郵件附件發送給足部護理提供者。 儘管目前很難在不違反保密規定的情況下安全地共享此類臨床信息，但廣泛使用手機照片來自我監測 DFU 進展可能是未來足部護理的重要一步。

糖尿病足潰瘍的治療費用昂貴

糖尿病足潰瘍可能需要長期的強化治療，包括傷口敷料、藥物治療和頻繁監測。 這種延長的治療期可能導致治療費用增加。 糖尿病足潰瘍的治療通常需要涉及多位醫療保健專業人員的多學科方法，包括足病醫生、傷口護理專家、內分泌學家和血管外科醫生。 在不同的醫療保健提供者之間協調護理會增加總成本。

COVID-19 影響分析

COVID-19 大流行嚴重擾亂了全球 DFU 治療。 延遲評估潰瘍可能會對 DFU 癒合產生不利影響並導致截肢。

在大流行期間，電話和視頻診所幫助醫生解決了一些與患者在 COVID-19 封鎖期間無法就診有關的擔憂。 在科學界，構建人工智能 (AI) 算法以通過虛擬診所改善患者護理的嘗試得到了時尚前沿的支持。

俄烏衝突分析

烏克蘭有成千上萬的人由於無法獲得足夠的醫療保健服務而患上糖尿病足潰瘍，這使他們面臨截肢的巨大風險。 未能解決與慢性潰瘍和截肢相關的障礙可能會損害烏克蘭個人和公眾的健康。

加強初級和遠程護理、教導個人自我護理以及為糖尿病足護理提供適當的用品有可能顯著減少截肢、殘疾和死亡率。 在烏克蘭和其他衝突地區，充分的糖尿病足護理對於當地居民的健康和受影響國家在危機後的恢復至關重要。

內容

第一章調查方法及範圍

  • 調查方法
  • 調查目的和範圍

第 2 章定義和概述

第 3 章執行摘要

  • 按產品類型分類的摘要
  • 按潰瘍類型分類的片段
  • 最終用戶的片段
  • 區域摘要

第四章市場動態

  • 影響因素
    • 主持人
      • 糖尿病足潰瘍的患病率增加
    • 約束因素
      • 糖尿病足潰瘍的高昂治療費用
    • 機會
      • 治療方案的技術進步
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 法律法規分析

第 6 章 COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情景
    • COVID-19 期間的情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格和動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按產品類型

  • 傷口敷料
  • 生物製品
  • 其他

第 8 章按潰瘍類型

  • 神經性潰瘍
  • 神經/缺血性潰瘍

第 9 章最終用戶

  • 醫院
  • 醫務室
  • 門診手術中心
  • 家庭護理

第10章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第11章競爭格局

  • 競爭場景
  • 市場情況/份額分析
  • 併購分析

第12章公司簡介

  • ConvaTec Inc
  • Acelity LP Inc
  • 3M Healthcare
  • Organogenesis Inc
  • Coloplast Corp
  • Smith & Nephew Plc
  • B Braun Melsungen AG
  • Medline Industries Inc
  • Medtronic
  • Molnlycke Healthcare AB

第13章 附錄

簡介目錄
Product Code: PH20

Market Overview

The global diabetic foot ulcers market reached US$ 5,812.7 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 9,300.6 million by 2030. The diabetic foot ulcers market is expected to exhibit a CAGR of 6.2% during the forecast period (2023-2030). Diabetic foot ulcers are one of the most prevalent consequences in persons with poorly managed diabetes mellitus. Inadequate glycemic management, underlying neuropathy, peripheral vascular disease, or inadequate foot care are common causes of diabetic foot ulcers.

Diabetic foot ulcers are one of the most serious consequences that diabetics confront since the body's wound healing capacity has been greatly diminished. It is the creation of a wound, generally in the patient's foot, which decomposes quickly and leads to the generation of infectious germs in that specific location.

Market Dynamics

Increase in the Prevalence Of Diabetic Foot Ulcers

One of the most serious and severe consequences of diabetes is diabetic foot ulcer. As the prevalence of disease increases, so do the number of problems. Various variables, including rising age, sedentary lifestyle, and longer duration of diabetes mellitus, have all contributed to an increase in the occurrence of diabetic foot ulcers.

Technological Advancements In Treatment Options

Newer mobile phones can take high-resolution DFU images that are equivalent to those taken by commercial digital cameras. Many patients currently self-monitor their DFUs using cell phone photographs. Some patients painstakingly bring these photographs to foot clinics throughout their follow-up appointments for DFU therapy to serially track their wound development.

Patients occasionally send images to footcare providers online or as email attachments. Although the safety difficulties associated with the secure sharing of such clinical information without breaching confidentiality are currently hard, the widespread use of mobile phone photography for self-monitoring of DFU development may transform future foot care.

High Cost For Treatment Of Diabetic Foot Ulcers

Diabetic foot ulcers may need long-term and intense treatment, such as wound dressings, medicines, and frequent monitoring. This prolonged duration may lead to increased treatment expenses. Diabetic foot ulcer treatment often entails a multidisciplinary approach including several healthcare experts such as podiatrists, wound care specialists, endocrinologists, and vascular surgeons. Coordination of care among various providers may increase total costs.

COVID-19 Impact Analysis

The COVID-19 pandemic caused significant hurdles in DFU treatment over the world. Delays in ulcer evaluations may have a negative impact on DFU healing, potentially leading to amputations.

During the pandemic, telephone and video clinics assisted physicians in addressing some of the concerns connected to patients' incapacity to attend medical clinics during the COVID-19 lock-down period. Attempts by the scientific community to build artificial intelligence (AI) algorithms to improve patient care through virtual clinics gained traction in response to the epidemic.

Russia- Ukraine Conflcit Analysis

Due to the country's inadequate access to healthcare services, thousands of individuals in Ukraine suffer from diabetic foot ulcers and are consequently at significant risk of lower limb amputation. Individual and public health in Ukraine may suffer if the handicap associated with chronic ulcers and amputations is not addressed.

Strengthening primary and remote care, teaching individuals on self-care, and providing appropriate supplies for diabetic foot treatment have the potential to significantly reduce amputations, disability, and mortality. Adequate diabetic foot care in Ukraine and other conflict-torn regions is critical for the health of the local population and the ability of affected countries to recover after the crisis.

Segment Analysis

The Neuropathic Segment Is Expected To Have The Market Share Of Around 46.5% Over The Forecast Period.

Neuropathic ulcers are the most prevalent form of ulcer encountered in patients. As a result, this sector is dominated in the market in this category. This kind of disease is the most difficult to manage since it causes significant pain and agony to the individual; as a result, the usage of medications increases, helping to raise the revenue return for the diabetic foot ulcer treatment market.

Neuropathic ulcers arise when a patient with impaired peripheral nervous system neurological function has pressure sites that induce ulceration via the epidermal and dermal tissue layers. This is a frequent ailment that affects the foot and occasionally other sections of the body.

Geographical Analysis

North America is Expected to be the Dominating Region During The Forecast Period.

The North America region holds the largest share of the global diabetic foot ulcers market accounting for around 37.7% in the forecast period. This is owing the large number of diabetic patients and adequate healthcare facilities in this region. Also, North America also has lengthy R&D facilities and approval periods. The country also contains cutting-edge biologics and wound care equipments for the treatment of these ulcers.

Competitive Landscape

The major global players include: ConvaTec Inc, Acelity LP Inc, 3M Healthcare, Organogenesis Inc, Coloplast Corp Smith & Nephew Plc, B Braun Melsungen AG Medline Industries Inc, Medtronic, Molnlycke Healthcare AB and others.

  • Why Purchase the Report?
  • To visualize the global diabetic foot ulcers market segmentation based on the product type, ulcer type, end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global diabetic foot ulcers market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global diabetic foot ulcers market report would provide approximately 92 tables, 108 figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Ulcer Type
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increased prevalence of diabetic foot ulcers
    • 4.1.2. Restraints
      • 4.1.2.1. High cost of treatment for Diabetic foot ulcers
    • 4.1.3. Opportunity
      • 4.1.3.1. Technological advancements in treatment options
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Post COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Wound Care Dressing
  • 7.2. Biologics
  • 7.3. Others

8. By Ulcer Type

  • 8.1. Neuropathic Ulcers
  • 8.2. Neuro-Ischemic Ulcers

9. By End User

  • 9.1. Hospitals
  • 9.2. Clinics
  • 9.3. Ambulatory Surgical Center
  • 9.4. Homecare Setting

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ulcer Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ulcer Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ulcer Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ulcer Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ulcer Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. ConvaTec Inc
  • 12.2. Acelity LP Inc
  • 12.3. 3M Healthcare
  • 12.4. Organogenesis Inc
  • 12.5. Coloplast Corp
  • 12.6. Smith & Nephew Plc
  • 12.7. B Braun Melsungen AG
  • 12.8. Medline Industries Inc
  • 12.9. Medtronic
  • 12.10. Molnlycke Healthcare AB

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us